Edition:
United States

Trillium Therapeutics Inc (TRIL.OQ)

TRIL.OQ on NASDAQ Stock Exchange Capital Market

6.70USD
23 Feb 2018
Change (% chg)

$-0.05 (-0.74%)
Prev Close
$6.75
Open
$6.85
Day's High
$7.00
Day's Low
$6.60
Volume
23,118
Avg. Vol
27,267
52-wk High
$13.30
52-wk Low
$4.10

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.97 December 23 Feb 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 2 2 2 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.67 1.67 1.67 1.67

Consensus Estimates Analysis

Sales and Profit Figures in Canadian Dollar (CAD)
Earnings and Dividend Figures in Canadian Dollar (CAD)
  # of Estimates Mean High Low 1 Year
Ago
Earnings (per share)
Quarter Ending Mar-18 1 -0.97 -0.97 -0.97 --
Quarter Ending Jun-18 1 -0.99 -0.99 -0.99 --
Year Ending Dec-18 2 -3.79 -3.70 -3.87 -2.78

Historical Surprises

Sales and Profit Figures in Canadian Dollar (CAD)
Earnings and Dividend Figures in Canadian Dollar (CAD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 0.00 0.00 0.00 0.00
Quarter Ending Jun-17 0.00 0.00 0.00 0.00
Quarter Ending Mar-17 0.00 0.00 0.00 0.00
Quarter Ending Dec-16 0.00 0.00 0.00 0.00
Quarter Ending Sep-16 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Sep-17 -1.24 -1.05 0.19 -15.32
Quarter Ending Jun-17 -1.37 -1.33 0.03 -2.56
Quarter Ending Mar-17 -1.17 -1.46 0.29 -24.26
Quarter Ending Dec-16 -1.12 -1.15 0.03 -3.14
Quarter Ending Sep-16 -1.02 -1.01 0.01 -1.46

Consensus Estimates Trend

Sales and Profit Figures in Canadian Dollar (CAD)
Earnings and Dividend Figures in Canadian Dollar (CAD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
Earnings (per share)
Quarter Ending Mar-18 -0.97 -0.97 -0.97 -0.97 --
Quarter Ending Jun-18 -0.99 -0.99 -0.99 -0.99 --
Year Ending Dec-18 -3.79 -3.79 -3.79 -3.79 -2.78

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Earnings
Quarter Ending Mar-18 0 0 0 0
Quarter Ending Jun-18 0 0 0 0
Year Ending Dec-18 0 0 0 0